home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

287 rows where filing_period = "second_quarter", filing_year = 2021 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: received_date (date)

issue_code 1

  • PHA · 287 ✖

filing_year 1

  • 2021 · 287 ✖

filing_period 1

  • second_quarter · 287 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2632549 4C COMMUNICATIONS, INC. c03c74ec-8196-46c1-a043-70cb0ec13da6 Q2 4C COMMUNICATIONS, INC. 323717 HEALTHCARE LEADERSHIP COUNCIL 2021 second_quarter PHA The Treat Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-02T11:57:23.323000-04:00
2632559 PENN AVENUE PARTNERS 3ce8fd8d-8939-41e6-a9d8-ee4aed14bb7f Q2 PENN AVENUE PARTNERS 400918672 ALKERMES, INC. 2021 second_quarter PHA Regulatory and legislative issues impacting Alkermes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-02T12:47:30.710000-04:00
2633071 STONINGTON GLOBAL f8c293a9-3cec-4c86-babd-e55028a78712 Q2 STONINGTON GLOBAL 401105189 SORRENTO THERAPEUTICS, INC. 2021 second_quarter PHA Regulatory approvals and funding for pharmaceutical products and devices Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 130000   0 0 2021-07-06T13:17:21.127000-04:00
2633848 PENN AVENUE PARTNERS 7c5ac628-ce96-4601-bd38-9fec094a62d0 Q2 PENN AVENUE PARTNERS 400918672 UNITEDHEALTH GROUP, INC. 2021 second_quarter PHA Pharmacy benefit related issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 90000   0 0 2021-07-07T17:47:08.467000-04:00
2633948 AMERICAN COLLEGE OF CLINICAL PHARMACY c73ff5b5-3718-401f-b944-79b0cd238fdc Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 second_quarter PHA Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-07-08T09:10:46.310000-04:00
2634068 WATKINS & EAGER PLLC 4fae6076-de3c-40f0-b42c-b762bb5ed069 Q2 WATKINS & EAGER PLLC 401104403 ZYNERBA PHARMACEUTICALS, INC. 2021 second_quarter PHA Providing services on behalf of Zynerba to the pharmaceutical industry Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-07-08T11:18:35.717000-04:00
2634673 INDEPENDENT PHARMACY COOPERATIVE b53db0a4-0d71-4208-bbe9-14010b33015e Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2021 second_quarter PHA IPC supports S. 1909/H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act. Support regulations/laws that would eliminate pharmacy DIR. IPC supports Pharmacists as Providers under Medicare Part B. IPC supports Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 2759/S. 1362 IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   30000 0 0 2021-07-09T13:41:25.140000-04:00
2634708 340B HEALTH 1743993d-d55b-47d0-9173-e07325a21413 Q2 340B HEALTH 316434 340B HEALTH 2021 second_quarter PHA The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.3203 - To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R.19 - Lower Costs, More Cures Act of 2021; Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   272268 0 0 2021-07-09T14:42:00.983000-04:00
2634854 BUCHANAN INGERSOLL & ROONEY PC 6e91c212-04f3-4999-a98a-3b55bf3d7fe7 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 GALEPHAR PHARMACEUTICAL RESEARCH INC. 2021 second_quarter PHA Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-10T07:10:54.357000-04:00
2634855 BUCHANAN INGERSOLL & ROONEY PC af5951c7-ed6d-482f-a200-1c8fde5f9c6d Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 OHEMO LIFE SCIENCES INC. 2021 second_quarter PHA Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-10T07:13:55.763000-04:00
2634860 BUCHANAN INGERSOLL & ROONEY PC b74668fc-880d-4f22-8ce7-cae67bc2124f Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2021 second_quarter PHA Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-10T07:15:57.160000-04:00
2635050 PANNONE LOPES DEVEREAUX & O'GARA LLC 5dbab130-0fbd-4032-aa13-0517058bf97c Q2 PANNONE LOPES DEVEREAUX & O'GARA LLC 401105501 AMGEN 2021 second_quarter PHA Prescription drug pricing.   9000   0 0 2021-07-12T09:09:55.760000-04:00
2635081 NATIONAL ASSOCIATION OF CHAIN DRUG STORES cdc9d2c4-beb6-4535-8521-9f28b0a543b8 Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2021 second_quarter PHA Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation. H.R. 1002 Debarment Enforcement of Bad Actor Registrants Act H.R. 1899 Ensuring Compliance Against Drug Diversion Act Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   260000 0 0 2021-07-12T10:46:29.487000-04:00
2635115 BUCHANAN INGERSOLL & ROONEY PC 484293c9-494f-4a01-acd1-f34e63b2c482 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 AIM IMMUNOTECH INC. 2021 second_quarter PHA Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH) Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Navy, Dept of,SENATE 40000   0 0 2021-07-12T11:27:08.793000-04:00
2635144 LUPIN PHARMACEUTICALS INC 1321c831-c121-462f-824c-40955827b58c Q2 LUPIN PHARMACEUTICALS INC 401104766 LUPIN PHARMACEUTICALS INC 2021 second_quarter PHA None HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)   202049 0 0 2021-07-12T11:53:37.030000-04:00
2635302 CRISPR THERAPEUTICS, INC. 7ea4b772-4387-4eaf-970e-f026bea3358d Q2 CRISPR THERAPEUTICS, INC. 401105184 CRISPR THERAPEUTICS, INC. 2021 second_quarter PHA Coverage & reimbursement for Cell and Gene Therapies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2021-07-12T13:52:29.563000-04:00
2635427 POLSINELLI PC 3939410d-c15a-473e-9e2c-e0630bd619ed Q2 POLSINELLI PC 314911 TEVA PHARMACEUTICALS USA, INC. 2021 second_quarter PHA Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-12T15:32:17.040000-04:00
2635857 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 067f0c87-268a-4a1e-8845-3689399904d7 Q2 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 401103605 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 2021 second_quarter PHA COVID-19 vaccine & therapeutic production, and pandemic protection. Pharmaceutical supply chain and domestic manufacturing HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-07-13T11:33:23.487000-04:00
2635913 RED+BLUE STRATEGIES 3d300760-1db8-4e02-8b4e-baf5b1473ab7 Q2 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2021 second_quarter PHA PL 117-2 - The American Rescue Plan Act Implementation - Issues related to policies focused on increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Issues related to Trump-era rules and regulations regarding Medicare rebate policies and PBM transparency. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-07-13T12:25:58.407000-04:00
2635920 RED+BLUE STRATEGIES f834780d-9852-4c10-a098-f9713189b91e Q2 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2021 second_quarter PHA PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 60000   0 0 2021-07-13T12:40:00.663000-04:00
2635958 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2e407914-87cb-4d4b-8eb3-378cdcc59dd9 Q2 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2021 second_quarter PHA OTC switch process -- no bill number Cures 2.0 -- no bill number Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   189000 0 0 2021-07-13T13:11:09.680000-04:00
2636349 MARSHALL & POPP, LLC b5a756ce-587a-4541-9981-7ebcf905a2ee Q2 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2021 second_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-13T17:21:09.987000-04:00
2636400 MARSHALL & POPP, LLC 57d25686-cb63-43c5-8555-5b1afb85bed1 Q2 MARSHALL & POPP, LLC 401105121 PFIZER, INC. 2021 second_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-13T17:31:16.673000-04:00
2636406 MARSHALL & POPP, LLC 3b5262a0-3de6-46fe-aa52-0bd5157a906f Q2 MARSHALL & POPP, LLC 401105121 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 second_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-13T17:35:18.060000-04:00
2636409 MARSHALL & POPP, LLC 99e043e9-f666-4333-a4e0-32bbb1487b63 Q2 MARSHALL & POPP, LLC 401105121 SANOFI U.S. SERVICES, INC. 2021 second_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-13T17:37:18.737000-04:00
2636497 HANCE SCARBOROUGH 43f75837-b11a-4a4a-8679-bd89269121fa Q2 HANCE SCARBOROUGH 17443 PHRMA 2021 second_quarter PHA Patent reform regarding pharmaceutical research & products. SENATE 30000   0 0 2021-07-14T00:09:45.030000-04:00
2636752 WAXMAN STRATEGIES 7bdb3a53-5a69-49a1-bc1f-44c808655aa3 Q2 WAXMAN STRATEGIES 401103693 340B HEALTH 2021 second_quarter PHA Issues affecting the 340B drug pricing program; Appropriations for 340B program. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-07-14T11:44:52.397000-04:00
2636857 FARRAGUT PARTNERS LLP d9a0b958-e99f-4e44-aba0-355e29136903 Q2 FARRAGUT PARTNERS LLP 401103938 COMMUNITY ONCOLOGY ALLIANCE 2021 second_quarter PHA Issues related to pharmacy benefit managers. HR 3258 TACT Act Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-14T12:43:22.297000-04:00
2636948 FARRAGUT PARTNERS LLP 3af014f0-dd08-4145-b9d0-2367ba6b93f9 Q2 FARRAGUT PARTNERS LLP 401103938 ONEONCOLOGY INC. 2021 second_quarter PHA Issues related to pharmacy benefit managers. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-14T13:27:50.200000-04:00
2637414 BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 88a4b57c-d2f7-40d0-998f-7eb3c22b59ae Q2 BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 401104621 BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 2021 second_quarter PHA HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   110000 0 0 2021-07-14T20:17:17.333000-04:00
2637507 ACG ADVOCACY 3de8514a-e6ae-45ca-9632-9d3d4ae55519 Q2 ACG ADVOCACY 2057 BAYER CROPSCIENCE LP 2021 second_quarter PHA Medication disposal. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-15T08:50:47.670000-04:00
2637553 RUBICON ADVISORS, LLC 31326ac8-1646-4210-8600-6f1064482272 Q2 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2021 second_quarter PHA Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2021-07-15T09:37:00.263000-04:00
2637554 RUBICON ADVISORS, LLC bf18b12e-53d5-423a-93ef-4e540d6c7ebf Q2 RUBICON ADVISORS, LLC 315091 DR. REDDY'S LABORATORIES, LTD 2021 second_quarter PHA Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2021-07-15T09:39:00.760000-04:00
2637556 RUBICON ADVISORS, LLC c6546c0c-f03f-44f8-b965-32c834c93015 Q2 RUBICON ADVISORS, LLC 315091 CONSCIOUS DISCIPLINE 2021 second_quarter PHA Medicare HOUSE OF REPRESENTATIVES,SENATE 67500   0 0 2021-07-15T09:40:01.693000-04:00
2637558 RUBICON ADVISORS, LLC 0229e5e9-9861-4d18-9bb1-386225aef5e1 Q2 RUBICON ADVISORS, LLC 315091 LANNETT COMPANY, INC 2021 second_quarter PHA Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2021-07-15T09:42:02.610000-04:00
2637559 RUBICON ADVISORS, LLC d76c0b24-4d4a-4009-867c-d6658c06a9ec Q2 RUBICON ADVISORS, LLC 315091 AVET PHARMACEUTICALS 2021 second_quarter PHA GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES 30000   0 0 2021-07-15T09:44:03.077000-04:00
2637562 ACADEMY OF MANAGED CARE PHARMACY a5d584dc-7af9-464c-8fea-9f644de4dce3 Q2 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2021 second_quarter PHA Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-07-15T09:45:04.193000-04:00
2637567 RUBICON ADVISORS, LLC dfe8876c-d138-4627-9231-0efe74a86b8e Q2 RUBICON ADVISORS, LLC 315091 ASCENDIS PHARMA, INC. 2021 second_quarter PHA Food and Drug Administration, Orphan Drugs Food & Drug Administration (FDA) 60000   0 0 2021-07-15T09:52:06.123000-04:00
2637809 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 54c331f9-1c41-4fc9-af25-db797c5482b9 Q2 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 323876 BLUE CROSS AND BLUE SHIELD OF KANSAS INC 2021 second_quarter PHA COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform; H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06) H.R. 2831 - Prompt Approval of Safe Generic Drugs Act Sponsor: Rep. Nanette Barragan (D-CA-44) Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2021-07-15T12:20:28.920000-04:00
2637857 KNIGHT CAPITOL CONSULTANTS 1252405d-0ca0-4879-8bc2-caa1f91446f1 Q2 KNIGHT CAPITOL CONSULTANTS 40036301 EQUASHIELD, LLC 2021 second_quarter PHA Provisions affecting vial reuse being discussed in connection with drug pricing legislation (no specific bills) Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-15T12:52:47.987000-04:00
2638156 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 47849297-beac-4e64-86f8-73d02404b3ef Q2 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2021 second_quarter PHA S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA),White House Office   370000 0 0 2021-07-15T14:21:25.210000-04:00
2638326 RED+BLUE STRATEGIES 3eb566f6-32ba-45b5-98bd-2653619b6878 Q2 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2021 second_quarter PHA S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2021-07-15T15:04:59.790000-04:00
2638582 HANCE SCARBOROUGH ba62e432-e669-4d5b-8889-17c9ccc0982c Q2 HANCE SCARBOROUGH 17443 BOEHRINGER INGELHEIM USA CORPORATION 2021 second_quarter PHA Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-15T16:02:09.783000-04:00
2638713 NELSON MULLINS RILEY & SCARBOROUGH 83ad9312-9648-4d1a-bc64-aecec4b42470 Q2 NELSON MULLINS RILEY & SCARBOROUGH 285871 HEMOPHILIA OF GEORGIA 2021 second_quarter PHA 340B Drug Pricing Program, Medicare, biomedical research, ACA implementation and COVID-19 response and relief legislation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-15T17:55:46.587000-04:00
2638986 PUBLIC CITIZEN 8f59bb4d-36cf-4daa-9fee-52c321e56a60 Q2 PUBLIC CITIZEN 32362 PUBLIC CITIZEN 2021 second_quarter PHA Covid-19 Vaccine Manufacturing and access and related funding, drug price negotiation, FAIR drug pricing Act, clinical trial cost transparency, HR 3 Lower drug prices now act, HR 2096-SACKLER Act, Affordable medications act, prescription drug price spike remedies, Medical Innovation act, National Biomedical research act, USTR access to medicines position, HR 3778/S 1976 (NOVID act), Aducanumab, S.1435-Affordable Prescriptions for Patients act, Consumer Product Safety Commission (CPSC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,White House Office   150000 0 0 2021-07-16T08:31:35.043000-04:00
2639167 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. b5a06b17-fb87-43e7-a14a-507afd417824 Q2 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2021 second_quarter PHA COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx Reform; Prescription Drugs; Prescription Drug Reform HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. HR 550 (117th Congress), Immunization Infrastructure Modernization Act of 2021, by Rep. Ann Kuster (D-NH). Amends the Public Health Service Act with respect to immunization system data modernization and expansion. HR 951 (117th Congress), Maternal Vaccination Act, by Rep. Terri Sewell (D-AL). Directs the Secretary of Health and Human Services to carry out a national campaign to increase awareness of the importance of maternal vaccinations for the health of pregnant and postpartum individuals and their children. HR 979 (117th Congress), Vaccine Fairness Act, by Rep. Angie Craig (D-MN). Directs the Secretary of Health and Human Services to submit to Congress a weekly report on COVID-19 vaccine distribution. HR 1452 (117th Congress), by Rep. Dan Crenshaw (R-TX). Directs the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines. HR 1978 (117th Congress), Protecting Seniors Through Immunization Act of 2021, by Rep. Ann Kuster (D-NH). Amends title XVIII of the Social Security Act to provide information regarding vaccines for seniors as part of the Medicare & You handbook and to ensure that the treatment of cost sharing for vaccines under Medicare Part D is consistent with the treatment of vaccines under Medicare Part B. HR 2347 (117th Congress), Strengthening the Vaccines for Children Program Act of 2021, by Rep. Kim Schrier (D- WA). Amends title XIX of the Social Security Act to ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program. HR 2831 (117th Congress), Prompt Approval of Safe Ge… Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,White House Office   150000 0 0 2021-07-16T10:11:25.923000-04:00
2639185 GUIDEWELL MUTUAL HOLDING CORPORATION 6e199a11-d153-407e-b541-08b2a212cf35 Q2 GUIDEWELL MUTUAL HOLDING CORPORATION 401103191 GUIDEWELL MUTUAL HOLDING CORPORATION 2021 second_quarter PHA COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx Reform; Prescription Drugs; Prescription Drug Reform HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. HR 550 (117th Congress), Immunization Infrastructure Modernization Act of 2021, by Rep. Ann Kuster (D-NH). Amends the Public Health Service Act with respect to immunization system data modernization and expansion. HR 951 (117th Congress), Maternal Vaccination Act, by Rep. Terri Sewell (D-AL). Directs the Secretary of Health and Human Services to carry out a national campaign to increase awareness of the importance of maternal vaccinations for the health of pregnant and postpartum individuals and their children. HR 979 (117th Congress), Vaccine Fairness Act, by Rep. Angie Craig (D-MN). Directs the Secretary of Health and Human Services to submit to Congress a weekly report on COVID-19 vaccine distribution. HR 1452 (117th Congress), by Rep. Dan Crenshaw (R-TX). Directs the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines. HR 1978 (117th Congress), Protecting Seniors Through Immunization Act of 2021, by Rep. Ann Kuster (D-NH). Amends title XVIII of the Social Security Act to provide information regarding vaccines for seniors as part of the Medicare & You handbook and to ensure that the treatment of cost sharing for vaccines under Medicare Part D is consistent with the treatment of vaccines under Medicare Part B. HR 2347 (117th Congress), Strengthening the Vaccines for Children Program Act of 2021, by Rep. Kim Schrier (D- WA). Amends title XIX of the Social Security Act to ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program. HR 2831 (117th Congress), Prompt Approval of Safe Ge… Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office     0 0 2021-07-16T10:16:32.493000-04:00
2639361 BROWN & FORTUNATO, P.C. 83c41352-7527-44a2-8df5-db93784ddf6b Q2 BROWN & FORTUNATO, P.C. 401104878 PROMPTCARE COMPANIES, INC. 2021 second_quarter PHA Issues related to Medicare home infusion therapy benefit and other health care issues. Issues related to the Medicare DMEPOS competitive bidding program and Medicare coverage and payment for non-invasive ventilators. Centers For Medicare and Medicaid Services (CMS) 20000   0 0 2021-07-16T10:52:10.090000-04:00
2639655 KOUNTOUPES DENHAM CARR & REID, LLC 171d882f-aebf-4027-a334-b5afdb3d3f46 Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 GLENMARK PHARMACEUTICALS, INC., USA 2021 second_quarter PHA Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T11:58:29.223000-04:00
2639771 AMERICAN VETERINARY MEDICAL ASSOCIATION 2b0327da-cd15-45e0-94a6-56e63de90593 Q2 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2021 second_quarter PHA Prescription Mandate Legislation Draft Compounding Guidance (GFI 256) H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S. 1698 Hemp Access and Consumer Safety Act (Mark) Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 220000   0 0 2021-07-16T12:20:52.393000-04:00
2640168 AARP f61a6f6d-a6c0-49cf-b666-b5d3906b0436 2A AARP 1694 AARP 2021 second_quarter PHA No bill number. Discussed prescription drugs and Medicare. No bill number - FY 2022 Agriculture, Rural Development & FDA Appropriations. Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Equal Employment Opportunity Commission (EEOC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Transportation Safety Board (NTSB),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office   2720000 0 0 2021-07-16T13:47:26.323000-04:00
2640191 HANCE SCARBOROUGH 1d6e9316-2e8a-4790-a86a-d59b412ead57 Q2 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2021 second_quarter PHA Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T13:48:27.723000-04:00
2640269 FLYNN & ASSOCIATES, INC. a8e85ca9-e28e-4ebb-a931-a1fdaee05f64 Q2 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2021 second_quarter PHA H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-16T14:06:47.567000-04:00
2640375 LINCOLN PARK GROUP L.L.C. ca2c3809-4156-41e0-93f2-e246f9b17b50 Q2 LINCOLN PARK GROUP L.L.C. 401104374 CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2021 second_quarter PHA Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-16T14:36:12.057000-04:00
2640599 KOUNTOUPES DENHAM CARR & REID, LLC 4477ae4b-f7e3-4756-9021-7c8281533333 Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2021 second_quarter PHA General issues related to over the counter pharmaceuticals, pharmaceutical supply chain and country of origin labeling, including S.1260, United States Innovation and Competition Act of 2021. Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act. Issues related to supplements. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T15:21:20.090000-04:00
2640717 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 7a55d00c-8a21-4524-8595-98cd4edd1465 Q2 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 39121 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 2021 second_quarter PHA Met with Senate staff regarding prescription drug reform. HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2021-07-16T15:44:46.520000-04:00
2640905 FORBES-TATE 5d894fd8-2b21-4fc2-b362-b9d5d38fb1f8 Q2 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 second_quarter PHA Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T16:23:35.373000-04:00
2640977 BROYDRICK & ASSOCIATES 049dbb77-da45-4623-af23-5f21842fb989 Q2 BROYDRICK & ASSOCIATES 7268 EXELA PHARMA SCIENCES 2021 second_quarter PHA Drug shortages and FDA approval, USTR acceptance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-16T16:35:57.020000-04:00
2641048 BROYDRICK & ASSOCIATES a0c67346-44bd-4fa8-b294-a5affa70fc4c Q2 BROYDRICK & ASSOCIATES 7268 TONIX PHARMACEUTICALS 2021 second_quarter PHA Funding new drug for PTSD and COVID 19. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-16T16:48:24.467000-04:00
2641049 SIMS STRATEGIES, LLC 4065651e-1e35-4abb-9e2b-dc6677f61c50 Q2 SIMS STRATEGIES, LLC 401104546 AMAG PHARMACEUTICAL 2021 second_quarter PHA Pharmaceutical issues related to womens health product access. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-16T16:48:24.930000-04:00
2641234 FORBES-TATE 776eae36-0434-4205-980b-9a3259a23910 Q2 FORBES-TATE 400976792 MERCK 2021 second_quarter PHA Issues related to prescription drug pricing, vaccines, animal health, and maternal health. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T17:22:15.677000-04:00
2641297 FOLEY & LARDNER LLP b35eb576-d7b2-4224-a94e-3edd445c5fbc Q2 FOLEY & LARDNER LLP 15042 BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY) 2021 second_quarter PHA Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-16T17:41:31.253000-04:00
2641586 REPUBLIC CONSULTING, LLC 401fd9e9-8164-4011-ab93-153f22cbe072 Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 second_quarter PHA Monitored Health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T09:41:27.690000-04:00
2641670 FORBES-TATE ea16dba0-542f-49bf-aaad-877acd74b862 Q2 FORBES-TATE 400976792 PHRMA 2021 second_quarter PHA Issues pertaining to prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-17T10:41:06.520000-04:00
2642114 BROWNSTEIN HYATT FARBER SCHRECK, LLP 29cbeb88-4060-4fed-aa45-772d4057c895 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 AKTIV PHARMA GROUP 2021 second_quarter PHA Supply chain issues related to production of pharmaceuticals SENATE 20000   0 0 2021-07-17T14:37:04.297000-04:00
2642160 THE KUTLER GROUP 6053acee-e313-40cb-8a70-f82c9e89efcb Q2 THE KUTLER GROUP 401103966 PRIME THERAPEUTICS 2021 second_quarter PHA drug pricing issues HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2021-07-17T15:01:19.390000-04:00
2642223 CAPITOL COUNSEL LLC c6676808-7b2e-41b1-8138-f8f18a874722 Q2 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 second_quarter PHA Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-17T15:21:38.317000-04:00
2642394 FORBES-TATE 3f6ee994-509c-4069-8db8-c2fe86ffa001 Q2 FORBES-TATE 400976792 INDEPENDENT PHARMACY COOPERATIVE 2021 second_quarter PHA Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T16:35:30.723000-04:00
2642628 KNIGHT CAPITOL CONSULTANTS 445214e9-2d51-42b8-b5c0-c239a80ce9e7 2A KNIGHT CAPITOL CONSULTANTS 40036301 REGENXBIO 2021 second_quarter PHA Possible legislation which may affect Food and Drug Administration review of biologic products (no specific bill) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-17T21:44:39.107000-04:00
2642643 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 3a55754e-9fb8-4c68-b20c-1b389ddd46d3 Q2 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2021 second_quarter PHA Compounding, preparation, packaging and dispensing of radiopharmaceuticals Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE   52000 0 0 2021-07-17T21:58:42.947000-04:00
2643277 FORBES-TATE 2063e0e5-7dc1-46b0-b6cf-ee2b75f6d915 Q2 FORBES-TATE 400976792 VERDE TECHNOLOGIES 2021 second_quarter PHA Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-18T15:17:38.590000-04:00
2643413 E3 STRATEGIC CONSULTING GROUP 65710229-de48-4b49-bce3-a728f0026e2d Q2 E3 STRATEGIC CONSULTING GROUP 401104104 HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) 2021 second_quarter PHA Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-18T16:32:17.750000-04:00
2643414 E3 STRATEGIC CONSULTING GROUP 79b8b412-37a9-4907-a842-c35433b02a77 Q2 E3 STRATEGIC CONSULTING GROUP 401104104 PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION 2021 second_quarter PHA Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-18T16:33:18.220000-04:00
2643497 POLARIS GOVERNMENT RELATIONS, LLC 3c5518be-c173-4bbd-9e1e-b6975c6c3ef4 Q2 POLARIS GOVERNMENT RELATIONS, LLC 307730 CIGNA CORPORATION 2021 second_quarter PHA Issues related to drug pricing, generally HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2021-07-18T17:06:43.220000-04:00
2643778 TARPLIN, DOWNS & YOUNG, LLC 58933e38-8441-4745-a82d-55e841f13ab7 Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2021 second_quarter PHA Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-18T20:23:14.283000-04:00
2643808 TARPLIN, DOWNS & YOUNG, LLC 02866f7c-ebd8-4e5e-9808-db7f3eac131a Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2021 second_quarter PHA H.R. 1319, American Rescue Plan of 2021 no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2021-07-18T20:41:21.610000-04:00
2644042 VAN SCOYOC ASSOCIATES 65579070-a332-4916-a928-7bf0706bfee8 Q2 VAN SCOYOC ASSOCIATES 39837 ZEBRA TECHNOLOGIES CORP. 2021 second_quarter PHA Temperature monitoring technology for COVID-19 vaccines, Domestic and International distribution related issues Temperature monitoring technology, generally SENATE 30000   0 0 2021-07-19T07:01:21.787000-04:00
2644339 ELI LILLY AND COMPANY be8f4150-18e0-4fc7-b53c-f93607e4df24 Q2 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2021 second_quarter PHA Hospital discounts; 340B program Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1675000 0 0 2021-07-19T09:07:34.960000-04:00
2644561 M.J. SIMON & COMPANY, LLC a9d4ecb7-391a-4001-9e26-7f0a5f35b60c Q2 M.J. SIMON & COMPANY, LLC 40026223 NOBELPHARMA AMERICA 2021 second_quarter PHA FDA inspections HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-07-19T09:44:21.133000-04:00
2644597 TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) bb283776-a866-4bf8-87c7-02de865d100b Q2 TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) 90250 AMAG PHARMACEUTICAL 2021 second_quarter PHA Pharmaceutical issues; access to women's health pharmaceutical products. HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2021-07-19T09:48:28.113000-04:00
2644937 MOVEON.ORG CIVIC ACTION 0b9b428d-c9dc-4dbb-8f75-8a90a56b72eb Q2 MOVEON.ORG CIVIC ACTION 401106098 MOVEON.ORG CIVIC ACTION 2021 second_quarter PHA HR 3, Elijah E. Cummings Lower Drug Costs Now Act; S 898, Fair Accountability and Innovative Research Drug Pricing Act of 2021 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2021-07-19T10:38:44.127000-04:00
2645332 CHRISTOPHER HEINZ 6b016906-7ad7-49d4-89e5-db5352bf3ac9 Q2 CHRISTOPHER HEINZ 318298 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2021 second_quarter PHA Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-07-19T11:16:08.523000-04:00
2645456 KOUNTOUPES DENHAM CARR & REID, LLC 715b36a1-42db-43d4-b137-06f95b134b3f Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CVS HEALTH 2021 second_quarter PHA General education about the pharmacy benefit manager/pharmacy and insurance industry. Issues related to drug pricing. Issues related to the drug supply chain. Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to the implementation of H.R. 1319, The American Rescue Plan, including provisions related to vaccine distribution. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-19T11:28:39.737000-04:00
2645679 LUNGREN LOPINA LLC f0f10825-50d4-441a-af7d-e6763a712f65 Q2 LUNGREN LOPINA LLC 401103314 AMPAC FINE CHEMICALS 2021 second_quarter PHA Fair treatment for US based pharmaceutical ingredients Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-19T11:50:34.520000-04:00
2645984 BROWNSTEIN HYATT FARBER SCHRECK, LLP 41e6017c-e185-40ed-8662-2794d1367d33 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 WALGREEN CO. 2021 second_quarter PHA Pharmacist provider status, Pharmacy benefits on military bases, Issues related to COVID-19 relief H.R.1319 - American Rescue Plan Act of 2021 HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) 60000   0 0 2021-07-19T12:17:40.427000-04:00
2646160 KOUNTOUPES DENHAM CARR & REID, LLC e8fbf3a0-225d-4db5-933b-8a3a9b3588e8 Q2 KOUNTOUPES DENHAM CARR & REID, LLC 320918 BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) 2021 second_quarter PHA Issues related to the cost of care and protecting patient access to blood cancer treatment. Issues related to specialty drug tiers. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2021-07-19T12:36:20.180000-04:00
2646199 THORSEN FRENCH ADVOCACY LLC 331ea68b-2029-4799-a620-6f4446477a91 Q2 THORSEN FRENCH ADVOCACY LLC 400599826 HEALTHCARE DISTRIBUTION ALLIANCE 2021 second_quarter PHA Issues related to regulation of prescription opioid medication. Issues related to vaccine distribution. H.R.133: Consolidated Appropriations Act, 2021. H.R.786: Supporting State and Local Leaders Act. H.R.768: Block, Report, And Suspend Suspicious Shipments Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-07-19T12:40:30.660000-04:00
2646207 FOLEY & LARDNER LLP 133024d4-768c-492c-bed6-675d44e0bef5 Q2 FOLEY & LARDNER LLP 15042 ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY 2021 second_quarter PHA FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-07-19T12:41:32.600000-04:00
2646289 THORSEN FRENCH ADVOCACY LLC 1a7e0d23-9588-469b-a9fb-df615739807a Q2 THORSEN FRENCH ADVOCACY LLC 400599826 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 second_quarter PHA Issues related to pharmaceutical market value. Global supply chain. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-07-19T12:49:56.397000-04:00
2646418 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 4534f03a-238e-4a2a-a057-e56f2ca91f47 Q2 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2021 second_quarter PHA 340B Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   32870 0 0 2021-07-19T13:03:27.927000-04:00
2646749 SUMMIT PUBLIC AFFAIRS e75e60d9-1d19-4db5-b238-c8a266c6db1f Q2 SUMMIT PUBLIC AFFAIRS 401105467 VANDA PHARMACEUTICALS INC. 2021 second_quarter PHA Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Implementation of the American Rescue Plan Act of 2021 (Pub. L. No. 117-7). 21st Century Cures Act 2.0 (proposed legislation). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-07-19T13:45:44.917000-04:00
2646792 TARPLIN, DOWNS & YOUNG, LLC c1247a24-8f46-4d4c-9d83-7a946fdab839 2A TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2021 second_quarter PHA Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-19T13:48:53.687000-04:00
2646957 TARPLIN, DOWNS & YOUNG, LLC 7fcfa42e-7a57-4e0e-bf45-d7c0f7791c80 2A TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2021 second_quarter PHA H.R. 1319, American Rescue Plan of 2021 implementation no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2021-07-19T14:05:28.917000-04:00
2647246 GOVERNMENT COUNSEL, LLC b100644f-f822-42d6-aceb-3ba023d970ba Q2 GOVERNMENT COUNSEL, LLC 401105070 HEALTHCARE DISTRIBUTION ALLIANCE 2021 second_quarter PHA H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; General issues relating to implementation of Public Law 113-54 (DSCSA;Pandemic Vaccine Tracking Improvement Act Discussion Draft. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-07-19T14:25:27.810000-04:00
2647648 TARPLIN, DOWNS & YOUNG, LLC feb66008-6093-4d35-83ab-1fd59a58e1df Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2021 second_quarter PHA Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-07-19T14:57:05.963000-04:00
2647784 ISEMAN & ASSOCIATES LLC a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2 Q2 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2021 second_quarter PHA Monitoring biotech legislation; prescription drug prices HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-07-19T15:06:36.883000-04:00
2648235 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 79b788b5-90ab-4b1b-8fb4-4d7efd1cf07d Q2 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 400395865 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 2021 second_quarter PHA H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act Issue: Requested clarification on certain key provisions reducing patients' access to medically-necessary treatments. HOUSE OF REPRESENTATIVES,SENATE,White House Office   60000 0 0 2021-07-19T15:38:21.937000-04:00
2648301 THERMO FISHER SCIENTIFIC INC. e9aaa50d-96ad-4e23-9280-fad3b45cc608 Q2 THERMO FISHER SCIENTIFIC INC. 323251 THERMO FISHER SCIENTIFIC INC 2021 second_quarter PHA Worker training program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   1020000 0 0 2021-07-19T15:42:35.600000-04:00
2648684 NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS c6c07931-e4f6-4c73-84cf-6ec9792a288b Q2 NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS 26808 NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS 2021 second_quarter PHA H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act): This bill establishes several programs and requirements relating to the prices of prescription drugs. H.R. 19 (Lower Costs, More Cures Act of 2021): To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes. H.R. 3775 (State-Based Universal Health Care Act of 2021): To amend title I of the Patient Protection and Affordable Care Act to authorize the establishment of, and provide support for, State-based universal health care systems that provide comprehensive health benefits to State residents, and for other purposes. S. 1180 (Choose Medicare Act): Would establish a Medicare Part E that individuals and employers can opt into. H.R. 1319 (American Rescue Plan Act): To provide for reconciliation pursuant to title II of S. Con. Res. 5. S. 1180: Choose Medicare Act: Would establish a Medicare Part E that individuals and employers can opt into. H.R. 1868 (Medicare Sequester): Extends a suspension of Medicare sequestration and make other technical changes to Medicare payments and Medicaid eligibility. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Treasury, Dept of,White House Office   330000 0 0 2021-07-19T16:07:00.123000-04:00
2648709 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9d88a5c3-b0f8-4aca-a67e-a16e727a34ac Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2021 second_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, White House Offices, and HHS and its subagencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Contact FDA concerning the practice of White Bagging and Brown Bagging patient medications. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   320000 0 0 2021-07-19T16:09:07.197000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 3465.436ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API